Evidence map›Paper›PMID 34038421›Full record

ArticlePLoS medicine2021

Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study.

John Woodford, Ashley Gillman, Peter Jenvey, Jennie Roberts, Stephen Woolley, Bridget E Barber, Melissa Fernandez, Stephen Rose, Paul Thomas, Nicholas M Anstey and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02867059 (A Proof-of-concept Study to Assess the Effect of), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02867059 phase1completednot on this map

A Proof-of-concept Study to Assess the Effect of (+)-SJ000557733 (SJ733) Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants

TypeinterventionalSponsorMedicines for Malaria VentureRan2016 to 2016Enrolled17ConditionsPlasmodium Falciparum MalariaArms(+)-SJ000557733
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Safety and Efficacy of Tafenoquine forTherapeutics and clinical risk management · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

John WoodfordClinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0002-8363-5495
Ashley GillmanCommonwealth Scientific and Industrial Research Organisation, Brisbane, Australia.ORCID 0000-0001-9130-1092
Peter JenveyDepartment of Radiology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Jennie RobertsDepartment of Radiology, Royal Brisbane and Women's Hospital, Brisbane, Australia.ORCID 0000-0001-8296-6447
Stephen WoolleyClinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0002-9385-8975
Bridget E BarberClinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia.
Melissa FernandezClinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia.
Stephen RoseCommonwealth Scientific and Industrial Research Organisation, Brisbane, Australia.
Paul ThomasHerston Imaging Research Facility, Brisbane, Australia.ORCID 0000-0002-2420-0950
Nicholas M AnsteyGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.ORCID 0000-0002-2192-0506
James S McCarthyClinical Tropical Medicine Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0001-6596-9718
QIMR Berghofer Medical Research Institute · AUCommonwealth Scientific and Industrial Research Organisation · AURoyal Brisbane and Women's Hospital · AUThe University of Queensland · AUCharles Darwin University · AUNational Imaging Facility · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium vivax has been proposed to infect and replicate in the human spleen and bone marrow. Compared to Plasmodium falciparum, which is known to undergo microvascular tissue sequestration, little is known about the behavior of P. vivax outside of the circulating compartment. This may be due in part to difficulties in studying parasite location and activity in life. METHODS AND

findingsTo identify organ-specific changes during the early stages of P. vivax infection, we performed 18-F fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) at baseline and just prior to onset of clinical illness in P. vivax experimentally induced blood-stage malaria (IBSM) and compared findings to P. falciparum IBSM. Seven healthy, malaria-naive participants were enrolled from 3 IBSM trials: NCT02867059, ACTRN12616000174482, and ACTRN12619001085167. Imaging took place between 2016 and 2019 at the Herston Imaging Research Facility, Australia. Postinoculation imaging was performed after a median of 9 days in both species (n = 3 P. vivax; n = 4 P. falciparum). All participants were aged between 19 and 23 years, and 6/7 were male. Splenic volume (P. vivax: +28.8% [confidence interval (CI) +10.3% to +57.3%], P. falciparum: +22.9 [CI -15.3% to +61.1%]) and radiotracer uptake (P. vivax: +15.5% [CI -0.7% to +31.7%], P. falciparum: +5.5% [CI +1.4% to +9.6%]) increased following infection with each species, but more so in P. vivax infection (volume: p = 0.72, radiotracer uptake: p = 0.036). There was no change in FDG uptake in the bone marrow (P. vivax: +4.6% [CI -15.9% to +25.0%], P. falciparum: +3.2% [CI -3.2% to +9.6%]) or liver (P. vivax: +6.2% [CI -8.7% to +21.1%], P. falciparum: -1.4% [CI -4.6% to +1.8%]) following infection with either species. In participants with P. vivax, hemoglobin, hematocrit, and platelet count decreased from baseline at the time of postinoculation imaging. Decrements in hemoglobin and hematocrit were significantly greater in participants with P. vivax infection compared to P. falciparum. The main limitations of this study are the small sample size and the inability of this tracer to differentiate between host and parasite metabolic activity.

conclusionsPET/MRI indicated greater splenic tropism and metabolic activity in early P. vivax infection compared to P. falciparum, supporting the hypothesis of splenic accumulation of P. vivax very early in infection. The absence of uptake in the bone marrow and liver suggests that, at least in early infection, these tissues do not harbor a large parasite biomass or do not provoke a prominent metabolic response. PET/MRI is a safe and noninvasive method to evaluate infection-associated organ changes in morphology and glucose metabolism.

Indexed as

Bone MarrowFemaleGlucoseHumansLiverMagnetic Resonance ImagingMalaria, FalciparumMalaria, VivaxMalePlasmodium falciparumPlasmodium vivaxPositron-Emission TomographyProspective StudiesQueenslandSpineSpleenGlucose

Identifiers

PMID34038421
PMCPMC8154100
OpenAlexW3165125729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.